BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2013
View Archived Issues
Lexicon Pharmaceuticals reports data on novel SGLT inhibitors for diabetes
Read More
The reclassification of endometrial carcinoma subgroup categorization on a genomic basis
Read More
Results of phase I expansion study of CC-223 reported
Read More
Preclinical data support therapeutic efficacy of UR-1102 for hyperuricemia and gout
Read More
Results from first-in-human study of VXM-01 reported
Read More
NOX-G16, a new candidate for type 1 diabetes
Read More
Roche presents novel agents for HCV infection
Read More
Forma Therapeutics and Cancer Research Technology to discover cancer drugs
Read More
Omthera Pharmaceuticals submits NDA for Epanova to the FDA
Read More
Boehringer Ingelheim discloses novel ACC-beta inhibitors
Read More
Lorus Therapeutics reports phase I data for LOR-253
Read More
Novel CRTH2 receptor antagonists prepared by Actelion Pharmaceuticals
Read More
Bellicum Pharmaceuticals begins trial of novel controlled dendritic cell immunotherapy
Read More
Chelsea Therapeutics resubmits Northera NDA
Read More
Olema Pharmaceuticals divulges new estrogen receptor modulators
Read More
Immunocore and GSK partner to discover ImmTACs against novel targets
Read More
Imetelstat shows promise in phase II trial for the treatment of essential thrombocythemia
Read More
Acorda Therapeutics acquires two neuropathic pain assets
Read More
Sensorion and Griffin receive Eurostars grant to develop new therapies for vestibular disorders
Read More
Sorrento and Ben-Gurion University sign agreement to develop anti-HCV antibodies
Read More
Calimmune commences phase I/II trial of gene medicine for HIV
Read More
Nuvilex to advance cell-encapsulated anticancer drug to phase III trials
Read More
Advancell grants Helsinn worldwide license to drug for chemotherapy-induced dermatological injuries
Read More
Kinex Pharmaceuticals to lead Orascovery program development in China
Read More
